Wyeth Financial Statements
Wyeth Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Wyeth Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 22,399.8 | 20,350.7 | 18,755.8 |
| Gross Profit ($ mil.) | 16,086.1 | 14,762.8 | 13,324.6 |
| Operating Income ($ mil.) | 6,075.6 | 5,151.8 | 4,457.5 |
| Total Net Income ($ mil.) | 4,616.0 | 4,196.7 | 3,656.3 |
| Diluted EPS (Net Income) | 3.38 | 3.08 | 2.70 |
Wyeth Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 5,945.4 | 5,710.6 | 5,763.5 |
| Gross Profit ($ mil.) | 4,261.4 | 4,148.6 | 4,072.1 |
| Operating Income ($ mil.) | 1,592.8 | 1,587.1 | 1,307.2 |
| Total Net Income ($ mil.) | 1,122.1 | 1,196.9 | 1,017.4 |
| Diluted EPS (Net Income) | 0.83 | 0.89 | 0.75 |
Wyeth Stock Quote & Chart
| 08/29/08 15:02:17 EST •
NYSE •
43.28
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Wyeth Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.47 | 3.75 | 1.56 |
| Price/Earnings Ratio | 12.71 | 16.34 | 15.82 |
| Price/Book Ratio | 2.88 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | 10.63 | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Wyeth Financial Ratios
Wyeth Competitive Intelligence
| Eli Lilly | Novartis | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,633.5 | 38,947.0 | 48,418.0 |
| Employees | 40,600 | 98,200 | 86,600 |
| Market Cap ($ mil.) | 54,960.2 | -- | 133,815.6 |
Competitive Landscape






